Aimei Health Technology Co., Ltd (AFJKU) Prices $60M IPO


Aimei Health Technology Co., Ltd (AFJKU) Prices $60M IPO

Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) announced the pricing of its $60 million IPO this evening. Its units are expected to begin trading on the Nasdaq under the symbol “AFJKU” on Monday, December 4, 2023. After the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on the Nasdaq under the symbols “AFJK” and “AFJKR”, respectively.

The company intends to pursue small cap targets that are domiciled in North America, Europe, or the Asia Pacific and are focused on healthcare innovation. Aimei Health Technology is led by its CEO and Secretary Juan Fernandez Pascual and CFO Heung Ming Wong. The company’s board of directors includes Lin Bao, Dr. Julianne Huh, and Robin Karlsen.

Total SPAC deal count for 2023 year-to-date is now 29. This offering is expected to close on Tuesday, December 6, 2023.

Spartan Capital Securities, LLC acted as sole book running manager in the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Hunter Taubman Fischer & Li LLC serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.